Dvo Wart Remover

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of warts, including plantar warts, flat warts, common warts, corns, and calluses.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is 1 mL administered twice daily. This regimen should be maintained for a total duration of 15 days.

Healthcare professionals are advised to ensure proper preparation and administration techniques are followed to optimize therapeutic outcomes.

Contraindications

Use of this product is contraindicated in the following situations:

Application on irritated skin or any area that is infected or reddened is prohibited due to the potential for exacerbating the condition. The product should not be applied to moles, birthmarks, warts with hair, genital warts, or warts located on the face or mucous membranes, as these areas may be sensitive or require specialized treatment.

Individuals with a known allergy to any ingredient in this product should avoid its use to prevent allergic reactions. Caution is advised for patients with diabetes, as the product may affect skin integrity or healing. Additionally, use during pregnancy or breastfeeding is contraindicated unless specifically directed by a healthcare practitioner.

The product should not be ingested, and it is also contraindicated if the cap is broken or missing, as this may compromise product integrity and safety.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire and flame. It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse. Healthcare professionals should advise patients to avoid contact with the eyes. In the event of contact, it is essential to flush the eyes with plenty of cool water. The product should not be swallowed; if ingestion occurs, immediate medical attention should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

Children should use this product only under adult supervision to ensure safety. It is also important to avoid prolonged exposure to air during use, as the substance may dissolve and crystallize easily. Users should recap the product immediately after each use and refrain from using it if the cap is broken or missing.

No specific laboratory tests are recommended for monitoring the use of this product. However, healthcare professionals should instruct patients to discontinue use and consult a doctor if they become pregnant or are attempting to become pregnant while using this product. Additionally, if irritation or redness occurs, worsens, or does not improve with continued use, patients should seek medical advice promptly.

Side Effects

Patients using this product may experience various adverse reactions. It is important to note that this product is for external use only and should be kept away from fire and flame due to its flammable nature. Additionally, it should be stored out of reach of children to prevent accidental ingestion or misuse.

In the event of contact with the eyes, patients should flush the eyes with plenty of cool water. If the product is swallowed, immediate medical attention should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

Patients are advised to discontinue use and consult a doctor if they become pregnant or are attempting to become pregnant while using this product. Furthermore, if irritation or redness occurs, worsens, or does not improve with continued use, medical advice should be sought.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dvo Wart Remover (salicylic acid 20% v/v). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should use this product under adult supervision to ensure safe administration and to monitor for any adverse effects. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product unless directed by a healthcare practitioner. It is essential for women of childbearing potential to discontinue use and consult a healthcare provider if they become pregnant or are planning to become pregnant while using this product. The potential risks associated with use during pregnancy have not been established, and caution is advised to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers should not use this medication while breastfeeding unless directed by a healthcare practitioner. There is no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, healthcare professionals should carefully consider the risks and benefits before prescribing this medication to lactating mothers.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring in this population.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical attention. Healthcare professionals should advise patients or caregivers to contact the Poison Control Center at 1-800-222-1222 without delay if the substance has been ingested.

Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are essential to ensure patient safety and effective recovery.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant or breastfeeding individuals unless directed by a healthcare practitioner. It is advised to discontinue use and consult a healthcare professional if pregnancy occurs or if there is an intention to become pregnant while using this product.

No non-teratogenic effects have been provided in the available data. Additionally, there is no information regarding nonclinical toxicology or animal pharmacology and toxicology in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that this product is intended for use by children only under adult supervision to ensure safety. It is crucial to inform patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be made aware that the product is flammable and must be kept away from fire and flame to prevent any hazardous situations. Additionally, it is important to instruct patients to keep the product out of reach of children to avoid accidental ingestion or misuse.

Healthcare providers should emphasize the importance of avoiding contact with the eyes. In the event of contact, patients should be instructed to flush their eyes with plenty of cool water and seek medical attention if irritation persists.

Patients must be cautioned against swallowing the product. If ingestion occurs, they should seek medical attention or contact the Poison Control Center at 1-800-222-1222 without delay.

Furthermore, healthcare providers should inform patients to avoid prolonged exposure to air during use, as the substance may dissolve and crystallize easily. It is advisable to recap the product immediately after each use to maintain its integrity. Lastly, patients should be instructed not to use the product if the cap is broken or missing, as this may compromise safety and effectiveness.

Storage and Handling

The product is classified as flammable and must be kept away from fire and flame. To ensure optimal performance and safety, it is essential to avoid prolonged exposure to air during use, as the substance may dissolve and crystallize easily. Users are advised to recap the container immediately after each use to maintain the integrity of the product. Additionally, the product should not be used if the cap is broken or missing, as this may compromise its effectiveness and safety.

Additional Clinical Information

Patients should administer the product twice daily at a dosage of 1 ml each time, with a total supply for 15 days. It is essential for children to use this product under adult supervision. Clinicians should advise patients to avoid prolonged exposure to air during use, as the substance may dissolve and crystallize easily. Patients are instructed to recap the product immediately after each use and to refrain from using it if the cap is broken or missing.

Additionally, patients should discontinue use and consult a doctor if they become pregnant or are attempting to become pregnant while using the product, or if they experience irritation or redness that worsens or does not improve with continued use.

Drug Information (PDF)

This file contains official product information for Dvo Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)